Pharmafile Logo
Pharmafocus logo
Advanced Search

Recipharm opens new GMP suite for clinical trial material

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) …

News
Press release
europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

Feature

BMS’ Opdivo scores eighth approval in Europe for bladder cancer

June 5, 2017
Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy

Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …

News

Merck KGaA signs potential $1 billion deal with UK biotech

June 5, 2017
Sales and Marketing F-star, Merck KGaA

UK biotech, F-Star, has scored a boost to its coffers with another link-up with a big pharma company, this time …

News
aging_-_hand

Latest prostate cancer research could provide boost for J&J

June 5, 2017
Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer

Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …

News
shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017
Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …

News
ovarian_cancer

Breakthrough treatment for ovarian cancer displays promising results

June 5, 2017
Research and Development, Sales and Marketing Amgen, Cancer, ICR, ovarian cancer

A treatment that specifically targets ovarian cancer cells has shown that half of women who took the drug experienced shrinking …

News

Tau pathology as the key to understanding Alzheimer’s disease

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …

Feature
White paper
abbvie_uk_france

Abbvie names new General Managers for UK and France

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment

Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …

Appointment
aedes_aegypti_mosquito

Research provides clues about Zika virus damage to foetal brains

June 2, 2017
Research and Development India, Zika, Zika virus

The Zika virus has been documented since 1947 and was first discovered to have infected a human in 1952. The …

News
sara_rajeswaran_v2

ABPI appoints new Executive Director of Government Affairs

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI

The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …

Appointment
astrazeneca_sign_sky

AZ’s Lynparza improves survival and maintains quality of life against ovarian cancer

June 2, 2017
Medical Communications, Research and Development AstraZeneca, lynparza

New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …

News
A example of a myelinated neuron

Old antibiotic offers potential cost-effective MS treatment

June 2, 2017
Medical Communications, Research and Development Myelin, multiple sclerosis

The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …

News

NICE U-turns to recommend Sanofi Gaucher disease drug

June 2, 2017
Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi

It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …

News
india_child_doctor

Childhood mortality from diarrhoea falls by third

June 2, 2017
Medical Communications Diarhhoea, India, Nigeria

A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade …

News

Clinical Trial Success: How Relationships Are Key

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …

Feature
White paper
hoffman

Silence Therapeutics instate new COO

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …

Appointment

Europe vs USA: New drug approvals

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …

Feature
White paper
640px-palace_of_westminster_at_night

What the life sciences industry wants from the next UK government

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …

Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026